The use of cryotherapy to freeze and destroy cancerous tumours is becoming more widely adopted but has encountered significant barriers in terms of funding and recognition from NICE. Some clinicians argue that UK patients are being disadvantaged. LOUISE FRAMPTON looks at how this procedure is advancing.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
